TickerFacts.

Insulet Corp (PODD): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$377.70M
Year ended 2025-12-31
$293.70M
Trailing 12 months to 2026-06-30
2009-12-31: -$52.46M2010-12-31: -$42.17M2011-12-31: -$36.57M2012-12-31: -$40.05M2013-12-31: -$3.96M2014-12-31: -$2.57M2015-12-31: -$23.16M2016-12-31: -$6.20M2017-12-31: -$32.50M2018-12-31: -$121.50M2019-12-31: -$65.30M2020-12-31: -$45.00M2021-12-31: -$180.00M2022-12-31: -$3.90M2023-12-31: $70.10M2024-12-31: $305.30M2025-12-31: $377.70M$377.70M
2009-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$377.70M+23.7%2026-02-18, From 2025-01-01
2024-12-31$305.30M+335.5%2026-02-18, From 2024-01-01
2023-12-31$70.10Mn/m2026-02-18, From 2023-01-01
2022-12-31-$3.90Mn/m2025-02-21, From 2022-01-01
2021-12-31-$180.00Mn/m2024-02-23, From 2021-01-01
2020-12-31-$45.00Mn/m2023-02-24, From 2020-01-01
2019-12-31-$65.30Mn/m2022-02-24, From 2019-01-01
2018-12-31-$121.50Mn/m2021-02-24, From 2018-01-01
2017-12-31-$32.50Mn/c2020-02-26, From 2017-01-01
2016-12-31-$6.20Mn/m2019-02-26, From 2016-01-01
2015-12-31-$23.16Mn/m2018-02-22, From 2015-01-01
2014-12-31-$2.57Mn/m2017-02-28, From 2014-01-01
2013-12-31-$3.96Mn/m2016-02-29, From 2013-01-01
2012-12-31-$40.05Mn/m2015-02-26, From 2012-01-01
2011-12-31-$36.57Mn/m2014-02-28, From 2011-01-01
2010-12-31-$42.17Mn/m2013-02-28, From 2010-01-01
2009-12-31-$52.46Mn/a2013-02-28, From 2009-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Insulet Corp (PODD)2025-12-31$377.70M+23.7%
Globus Medical Inc (GMED)2025-12-31$588.77M+45.3%
West Pharmaceutical Services Inc (WST)2025-12-31$468.90M+69.6%
MiniMed Group, Inc. (MMED)2026-04-24-$420.00Mn/m
ICU Medical Inc (ICUI)2025-12-31$91.80M-26.4%
Teleflex Inc (TFX)2025-12-31$1.45M-99.3%
Integra Lifesciences Holdings Corp (IART)2025-12-31-$31.05Mn/m
Dexcom Inc (DXCM)2025-12-31$1.08B+70.8%
Merit Medical Systems Inc (MMSI)2025-12-31$215.66M+16.2%

Compare PODD, GMED, WST, MMED side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗